Eli Lilly and Company operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Eli Lilly and Company with three other
companies in this sector in UNITED STATES :
Bristol-Myers Squibb Company
sales of $26.15 billion
of which 30%
was Prioritized Brands-Eliquis),
Takeda Pharmaceutical Company Limited
of which 97%
was Pharmaceutical Business), and
of which 100%
Eli Lilly and Company reported sales of $22.32 billion
December of 2019.
decrease of 9.1%
versus 2018, when the company's sales were $24.56 billion.